Mesenchymal Stem Cells in Inflammation Microenvironment Accelerates Hepatocellular Carcinoma Metastasis by Inducing Epithelial-Mesenchymal Transition

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Jing, Yingying ^a   Han, Zhipeng ^a   Liu, Yan ^a   Sun, Kai ^a   Zhang, Shanshan ^a   Jiang, Guocheng ^a   Li, Rong ^a   Gao, Lu ^a   Zhao, Xue ^a   Wu, Dong ^a   Cai, Xiong ^a   Wu, Mengchao ^a   Wei, Lixin ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; BETA CATENIN; GAMMA INTERFERON; NERVE CELL ADHESION MOLECULE; STAGE SPECIFIC EMBRYO ANTIGEN 4; TRANSCRIPTION FACTOR TWIST; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UVOMORULIN; VIMENTIN; CYTOKINE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER STAGING; CELL MOTILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MESENCHYMAL STEM CELL; METASTASIS POTENTIAL; MOUSE; NONHUMAN; OVERALL SURVIVAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; TUMOR MICROENVIRONMENT; TUMOR VOLUME; UPREGULATION; AGED; CYTOLOGY; LIVER TUMOR; MESENCHYMAL STROMA CELL; METABOLISM; METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; PROPORTIONAL HAZARDS MODEL; TREATMENT OUTCOME; WOUND HEALING;

AGED; CARCINOMA, HEPATOCELLULAR; CYTOKINES; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; INFLAMMATION; LIVER NEOPLASMS; MALE; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; PHENOTYPE; PROPORTIONAL HAZARDS MODELS; TRANSFORMING GROWTH FACTOR BETA; TREATMENT OUTCOME; WOUND HEALING;

EID: 84865527612     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043272     Document Type: Article

References (34)

1. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
2. Barry FP, Murphy JM, (2004) Mesenchymal stem cells: Clinical applications and biological characterization. Int J Biochem Cell Biol 36: 568-584.
3. da Silva Meirelles L, Chagastelles PC, Nardi NB, (2006) Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119: 2204-2213.
4. Noel D, Djouad F, Jorgense C, (2002) Regenerative medicine through mesenchymal stem cells for bone and cartilage repair. Curr Opin Investig Drugs 3: 1000-1004.
5. Quintavalla J, Uziel-Fusi S, Yin J, Boehnlein E, Pastor G, et al. (2002) Fluorescently labeled mesenchymal stem cells (mscs) maintain multilineage potential and can be detected following implantation into articular cartilage defects. Biomaterials 23: 109-119.
6. Moutsatsos IK, Turgeman G, Zhou S, Kurkalli BG, Pelled G, et al. (2001) Exogenously regulated stem cell-mediated gene therapy for bone regeneration. Mol Ther 3: 449-461.
7. Mantovani A, Allavena P, Sica A, Balkwill F, (2008) Cancer-related inflammation. Nature 454: 436-444.
8. Hall B, Andreeff M, Marini F (2007) The participation of mesenchymal stem cells in tumor stroma formation and their application as targeted-gene delivery vehicles. Handb Exp Pharmacol: 263-283.
9. Direkze NC, Hodivala-Dilke K, Jeffery R, Hunt T, Poulsom R, et al. (2004) Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts. Cancer Res 64: 8492-8495.
10. Hu M, Polyak K, (2008) Molecular characterisation of the tumour microenvironment in breast cancer. Eur J Cancer 44: 2760-2765.
11. Nasef A, Chapel A, Mazurier C, Bouchet S, Lopez M, et al. (2007) Identification of il-10 and tgf-beta transcripts involved in the inhibition of t-lymphocyte proliferation during cell contact with human mesenchymal stem cells. Gene Expr 13: 217-226.
12. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, et al. (2002) Human bone marrow stromal cells suppress t-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99: 3838-3843.
13. Coffelt SB, Marini FC, Watson K, Zwezdaryk KJ, Dembinski JL, et al. (2009) The pro-inflammatory peptide ll-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells. Proc Natl Acad Sci U S A 106: 3806-3811.
14. Popp FC, Renner P, Eggenhofer E, Slowik P, Geissler EK, et al. (2009) Mesenchymal stem cells as immunomodulators after liver transplantation. Liver Transpl 15: 1192-1198.
15. Povero D, Busletta C, Novo E, di Bonzo LV, Cannito S, et al. (2010) Liver fibrosis: A dynamic and potentially reversible process. Histol Histopathol 25: 1075-1091.
16. Larue L, Bellacosa A, (2005) Epithelial-mesenchymal transition in development and cancer: Role of phosphatidylinositol 3′ kinase/akt pathways. Oncogene 24: 7443-7454.
17. Martin FT, Dwyer RM, Kelly J, Khan S, Murphy JM, et al. (2010) Potential role of mesenchymal stem cells (mscs) in the breast tumour microenvironment: Stimulation of epithelial to mesenchymal transition (emt). Breast Cancer Res Treat 124: 317-326.
18. Yang MH, Chen CL, Chau GY, Chiou SH, Su CW, et al. (2009) Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma. Hepatology 50: 1464-1474.
19. Sun T, Zhao N, Zhao XL, Gu Q, Zhang SW, et al. (2010) Expression and functional significance of twist1 in hepatocellular carcinoma: Its role in vasculogenic mimicry. Hepatology 51: 545-556.
20. Gang EJ, Bosnakovski D, Figueiredo CA, Visser JW, Perlingeiro RC, (2007) Ssea-4 identifies mesenchymal stem cells from bone marrow. Blood 109: 1743-1751.
21. Pittenger MF, Martin BJ, (2004) Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 95: 9-20.
22. Xu W, Zhang X, Qian H, Zhu W, Sun X, et al. (2004) Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro. Exp Biol Med (Maywood) 229: 623-631.
23. Kumar S, Chanda D, Ponnazhagan S, (2008) Therapeutic potential of genetically modified mesenchymal stem cells. Gene Ther 15: 711-715.
24. Xu WT, Bian ZY, Fan QM, Li G, Tang TT, (2009) Human mesenchymal stem cells (hmscs) target osteosarcoma and promote its growth and pulmonary metastasis. Cancer Lett 281: 32-41.
25. Zavadil J, Bottinger EP, (2005) Tgf-beta and epithelial-to-mesenchymal transitions. Oncogene 24: 5764-5774.
26. Li GC, Ye QH, Xue YH, Sun HJ, Zhou HJ, et al. (2010) Human mesenchymal stem cells inhibit metastasis of a hepatocellular carcinoma model using the mhcc97-h cell line. Cancer Sci 101: 2546-2553.
27. Niess H, Bao Q, Conrad C, Zischek C, Notohamiprodjo M, et al. (2011) Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth ofhepatocellular carcinoma. Ann Surg 254: 767-74; discussion 774-5.
28. Poon RT, Fan ST, Lo CM, Liu CL, Wong J, (2007) Difference in tumor invasiveness in cirrhotic patients with hepatocellular carcinoma fulfilling the milan criteria treated by resection and transplantation: Impact on long-term survival. Ann Surg 245: 51-58.
29. Jin H, Morohashi S, Sato F, Kudo Y, Akasaka H, et al. (2010) Vimentin expression of esophageal squamous cell carcinoma and its aggressive potential for lymph node metastasis. Biomed Res 31: 105-112.
30. Roger L, Jullien L, Gire V, Roux P, (2010) Gain of oncogenic function of p53 mutants regulates e-cadherin expression uncoupled from cell invasion in colon cancer cells. J Cell Sci 123: 1295-1305.
31. Ren G, Su J, Zhang L, Zhao X, Ling W, et al. (2009) Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression. Stem Cells 27: 1954-1962.
32. Wu F, Yang LY, Li YF, Ou DP, Chen DP, et al. (2009) Novel role for epidermal growth factor-like domain 7 in metastasis of human hepatocellular carcinoma. Hepatology 50: 1839-1850.
33. Zhang X, Liu S, Hu T, Liu S, He Y, et al. (2009) Up-regulated microrna-143 transcribed by nuclear factor kappa b enhances hepatocarcinoma metastasis by repressing fibronectin expression. Hepatology 50: 490-499.
34. Chen L, Chan TH, Yuan YF, Hu L, Huang J, et al. (2010) Chd1l promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients. J Clin Invest 120: 1178-1191.